Your donation DOUBLED through April 30 thanks to anonymous donors who pledged to match your gift! DONATE NOW!
A collection of resources for individuals and families affected by Spinocerebellar Ataxia Type 5 (SCA5).
Spinocerebellar Ataxia type 5 (SCA5) is a specific form of Ataxia, which belongs to a group of inherited diseases that affects the central nervous system. As with the other inherited Ataxias, SCA5 is caused by the genetic defects that lead to impairment of specific nerve fibers carrying messages to and from the brain, resulting in degeneration of the cerebellum (the coordination center of the brain).
For complete information about symptoms, diagnosis, and treatment of Ataxia, visit our What is Ataxia? page. This page contains NAF’s resources that are specific to SCA5.
Sign up for our mailing list to stay up-to-date on Ataxia news.
Presented by Theresa Zesiewicz, MD, FAAN
This webinar gave an overview of the causes and symptoms of SCA5, the typical diagnostic journey for those affected, and what to expect for clinical care.
Presented by Adam Avery, PhD
This webinar taught us how SCA5 is studied and gave an overview of the current state of research and drug development for the disease.
SCA5 is a rare form of Ataxia. It is sometimes called “Lincoln’s Disease” because an 11th-generation SCA5 family is descended from the paternal grandparents of President Abraham Lincoln. However, SCA5 also is sometimes referred to as “Holmes Ataxia” after Dr. Gordon Holmes, who first described the condition in 1907.
SCA5 is characterized by uncoordinated gait (impaired balance when walking), limb and eye movements, and slurred speech (dysarthria).
Onset of the disease typically is marked by stumbling, difficulty climbing stairs, and losing balance while standing on one foot (such as in the shower). Ataxia of the hands and arms also is common in SCA5, although this usually is not as disabling as the gait Ataxia. Affected individuals might notice deterioration in
handwriting, fastening buttons, and other activities that require finger dexterity.
Slurred speech is also common, although this is typically not severe and the articulation problems generally are not significant enough to interfere with spoken communication. While some forms of Ataxia affect multiple parts of the brain, SCA5 is considered a “pure” cerebellar Ataxia, meaning only the cerebellum which coordinates movement is typically affected.
SCA5 tends to be a mild, slowly progressive form of Ataxia that generally does not shorten life span. It typically does not have the effects on breathing, swallowing, bowel and bladder control, thinking, and strength that results from some other forms of Ataxia. While many patients with SCA5 eventually use a mobility aid, only rarely does the disease lead to wheelchair dependence. The onset of symptoms for SCA5 can vary from ages 10 to 70, with average age at onset in the early 30s. Symptoms of SCA5 are rarely reported in individuals under the age of 20, however, these individuals may develop more severe symptoms over time.
SCA5 is a genetic disorder which means that it is an inherited disease. The abnormal gene responsible for this disease is passed along from generation to generation by family members who carry it. Genetic diseases like SCA 5 occur when one of the body’s 20,000 genes does not work properly. (Genes are microscopic structures within the cells of our bodies that contain instructions for every feature a person inherits from his
or her parents.)
SCA5 is an autosomal dominant disease and means that individuals of either sex are equally likely to inherit the gene and develop the disease, and the gene passes directly from one generation to the next without skipping generations. Each child of a person with SCA5 has a 50 percent chance of inheriting the SCA5 gene.
A neurologist is often the most helpful specialist in diagnosing spinocerebellar Ataxia type 5. A thorough neurologic examination can determine whether a person has symptoms typical of SCA5. If symptoms are consistent with this disease, a neurologist may order genetic testing to examine the DNA to determine the presence or absence of the abnormal gene that causes SCA5. A genetic counselor should be consulted prior to the genetic test. DNA is comprised of substances called nucleotides and the test involves examining a gene on chromosome 11 to determine if there are specific changes to the nucleotides. There are currently three known changes within this gene that have been shown to cause SCA5.
SCAsource provides Ataxia research news, directly from researchers to the Ataxia community. Visit SCAsource to see their full collection. Here is a collection of articles about SCA5.
Written by Sophia LeungEdited by Dr Hannah K Shorrock In SCA5, the N-terminus of β‑spectrin induces toxicity and therefore a new target for therapeutics to treat SCA5. The research group Read More…
Written by Dr. Sriram Jayabal Edited by Dr. David Bushart Eye movement deficits occur ubiquitously in spinocerebellar ataxias, even at early disease states, highlighting their clinical importance. Imagine the different Read More…
Written by Dr. Carolyn J. Adamski Edited by Dr. Judit M Perez Ortiz A research group uncovers a drug target to potentially correct motor phenotypes across several cerebellar ataxias. When someone is Read More…
Our generous donors help us fund promising Ataxia research and offer support services to people with Ataxia. Your gift today will help us continue to deliver on our mission to improve the lives of persons affected by Ataxia.
Join for FREE today! Become a part of the community that is working together to find a cure. As a member you will receive access to the latest Ataxia news with our e-newsletter and Generations publication.
